SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-017854
Filing Date
2020-02-12
Accepted
2020-02-12 08:00:48
Documents
6
Period of Report
2020-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207424-1_8k.htm 8-K 33924
2 EXHIBIT 4.1 tm207424d1_ex4-1.htm EX-4.1 166537
3 EXHIBIT 4.2 tm207424d1_ex4-2.htm EX-4.2 165734
4 EXHIBIT 10.1 tm207424d1_ex10-1.htm EX-10.1 696214
5 EXHIBIT 99.1 tm207424d1_ex99-1.htm EX-99.1 13023
6 GRAPHIC tm207424d1_ex99-1img01.jpg GRAPHIC 6872
  Complete submission text file 0001104659-20-017854.txt   1086393
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 20599983
SIC: 2834 Pharmaceutical Preparations